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Abstract 
Background: The optimal length of proximal margin for Siewert type II/III adenocarcinoma of the esophagogastric 
junction (AEJ) is still need to be clarified. The aim of the present study was to investigate the appropriate length of 
proximal margin for Siewert type II/III AEJ through transhiatal approach.
Methods: From September 2009 to December 2014, a total of 693 consecutive patients with Siewert type II/III AEJ 
were retrospectively analyzed. All patients received transhiatal R0 resection. The proximal margin length was meas-
ured immediately after resection. The prognostic value of proximal margin length on Siewert type II/III AEJ with 
transhiatal approach was analyzed.
Results: There were 404 cases of Siewert type II AEJ (58.3 %) and 289 cases of Siewert type III AEJ (41.7 %). Total gas-
trectomy was performed in 526 patients (75.9 %), and proximal gastrectomy was performed in 167 patients (24.1 %). 
The median length of the gross proximal margin was 2.4 (range 0.1–5.0) cm. Lymph node metastasis was the only 
independent prognostic predictor for Siewert type II AEJ. Tumor size and lymph node metastasis were independent 
prognostic predictors for Siewert type III AEJ.
Conclusions: For Siewert type II/III AEJ with esophageal invasion of 3 cm or less, proximal margin length does not 
influence the prognosis of patients after transhiatal curative gastrectomy.
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Background
Adenocarcinoma of the esophagogastric junction (AEJ) 
is defined as a tumor with an epicenter within the 5 cm 
proximal and distal of the esophagogastric junction 
(Keeney and Bauer 2006). The incidence of AEJ has 
been increasing in both Western and Asian countries 
(Hasegawa and Yoshikawa 2010). AEJ is classified into 
three types by Siewert in 1998 (Siewert and Stein 1998). 
Type I is defined as tumors with an epicenter of 1–5 cm 
above the junction, type II as epicenter within 1 cm above 
and 2 cm below the junction, type III as epicenter within 
2–5 cm below the junction (Parry et al. 2015). There are 
many unresolved issues on surgical management. Cura-
tive surgical resection is considered the mainstay of ther-
apy. The current trend of surgical resection for Siewert 
type III AEJ was radical gastrectomy (Gertler et al. 2011). 
However, the optimal surgical treatment for Siewert type 
II AEJ remains controversial. Previously, two phase III 
clinical trials performed in Japan and Netherlands dem-
onstrated that transthoracic approach could not improve 
the prognosis of patients with Siewert type II compared 
with transhiatal approach (Sasako et  al. 2006; Hulscher 
Open Access
*Correspondence:  zhanghwfmmu@126.com 
†Fan Feng, Yangzi Tian and Guanghui Xu contributed equally to this work
1 Department of Digestive Surgery, Xijing Hospital, Fourth Military 
Medical University, 127 West Changle Road, Xi’an 710032, Shaanxi, China
Full list of author information is available at the end of the article
Page 2 of 6Feng et al. SpringerPlus  (2016) 5:588 
et al. 2002). Thus, transhiatal approach is considered suf-
ficient for Siewert type II AEJ.
The optimal length of proximal margin for Siewert type 
II/III AEJ is still need to be clarified. Several reports have 
advocated that a resection margin of up to 10 cm is nec-
essary to prevent local recurrence (Ito et al. 2004; Mari-
ette et al. 2003). Barbour et al. reported that the prognosis 
of T2+ patients could be significantly improved if the 
length of proximal margin was greater than 3.8 cm (Bar-
bour et al. 2007). A recent study revealed that proximal 
margin length of more than 2 cm seemed satisfactory for 
patients with type II/III AEJ (Mine et al. 2013). Thus, the 
aim of the present study was to investigate the appropri-
ate length of proximal margin for Siewert type II/III AEJ 
through transhiatal approach.
Patients and methods
This study was performed in the Xijing Hospital of Diges-
tive Diseases affiliated to the Fourth Military Medical 
University. From September 2009 to December 2014, 
a total of 693 consecutive patients with AEJ were retro-
spectively analyzed. The inclusion criteria were: (1) Siew-
ert type II or III AEJ, (2) length of esophageal invasion 
was less than 3  cm, (3) underwent radical proximal or 
total gastrectomy, (4) with negative proximal margin, (5) 
pathological T2-4N0-3M0 tumor. The exclusion criteria 
were: (1) with neoadjuvant therapy, (2) with malignant 
tumor in other location, (3) underwent left thoracoab-
dominal approach. This study was approved by the Ethics 
Committee of Xijing Hospital, and written informed con-
sent was obtained from all patients before surgery.
All patients were treated with proximal or total gas-
trectomy with a combined D2 lymphadenectomy via a 
transhiatal approach. The proximal margin was sent for 
frozen-section pathological examination when the proxi-
mal margin length was considered inadequate. If the 
proximal margin was positive, further resection of distal 
esophagus with an additional 1–2  cm was performed. 
All the surgical procedure and the extent of lymph node 
clearance were based on the recommendations of the 
Japanese Gastric Cancer Treatment Guidelines (Japanese 
Gastric Cancer Association 2011).
The fresh specimen was cut open longitudinally imme-
diately after resection. Then the specimen was stretched 
maximally and fixed on a board. The length of proxi-
mal margin was measured and recorded by the surgeon. 
Additional proximal margin length was also measured 
if further resection of distal esophagus was performed. 
Then, specimens were fixed in 10  % neutral formalin 
immediately and embedded routinely for pathological 
examination.
Clinicopathological features including age, gender, 
tumor size, differentiation status, Bormann type, length 
of proximal margin, tumor depth, lymph node metasta-
sis, lymphatic–vascular invasion (LVI), neural invasion, 
operation time, blood loss and postoperative complica-
tions were collected. The patients were followed up till 
October 2015 by enhanced chest and abdominal CT 
every 6 months after discharge to evaluate tumor recur-
rence and distant metastasis.
Data were processed using SPSS 22.0 for Windows 
(SPSS Inc., Chicago, IL, USA). Discrete variables were 
analyzed using the Chi square test or Fisher’s exact test. 
Numerical variables were expressed as the mean  ±  SD 
unless otherwise stated. Significant predictors for sur-
vival identified by univariate analysis were further 
assessed by multivariate analysis using the logistic regres-
sion analysis. The P value was considered to be statisti-
cally significant at 5 % level.
Results
The clinicopathological and surgical related characteris-
tics of patients were summarized in Table 1. There were 
603 male (87.0  %) and 90 female (13.0  %). The patient 
age ranged from 22 to 87 years (median 61 years; mean 
60.4 years). There were 404 cases of Siewert type II AEJ 
(58.3 %) and 289 cases of Siewert type III AEJ (41.7 %). 
Total gastrectomy was performed in 526 patients 
(75.9 %), and proximal gastrectomy was performed in 167 
patients (24.1 %). The median length of the gross proxi-
mal margin was 2.4 (range 0.1–5.0) cm. The 5-year over-
all survival of Siewert type II and III was 54.7 and 50.8 %, 
respectively.
The prognostic factors for Siewert type II AEJ were 
summarized in Table  2. The results showed that tumor 
size, Borrmann type, tumor depth, lymph node metas-
tasis, TNM stage, lymphatic–vascular invasion, neural 
invasion and intraoperative blood loss were risk factors 
for the prognosis of Siewert type II AEJ. However, only 
lymph node metastasis were independent prognostic 
predictors (Table  3). The prognostic factors for Siewert 
type III AEJ were summarized in Table  4. The results 
showed that tumor size, lymph node metastasis, TNM 
stage, lymphatic–vascular invasion, neural invasion and 
intraoperative blood loss were risk factors for the prog-
nosis of Siewert type II AEJ. However, only tumor size 
and lymph node metastasis were independent prognos-
tic predictors (Table 5). It was worth mentioning that the 
proximal margin length was not a prognostic predictor 
for Siewert type II/III AEJ.
Discussion
The optimal length of proximal margin for Siewert type 
II/III AEJ remains controversial, especially for transhiatal 
approach. Thus, our present study mainly focused on the 
influence of proximal margin length on the prognosis 
Page 3 of 6Feng et al. SpringerPlus  (2016) 5:588 
Table 1 Clinicopathological and  surgical related charac-
teristics of gastric cancer patients
Characteristics Parameters
Age
 ≤60 330 (47.6 %)
 >60 363 (52.4 %)
Gender
 Male 603 (87.0 %)
 Female 90 (13.0 %)
Siewert type
 II 404 (58.3 %)
 III 289 (41.7 %)
Type of resection
 Proximal gastrectomy 167 (24.1 %)
 Total gastrectomy 526 (75.9 %)
Length of proximal margin 2.24 ± 0.99 cm
Tumor size
 ≤5 cm 410 (59.2 %)
 >5 cm 283 (40.8 %)
Differentiation status
 Well 54 (7.8 %)
 Moderately 254 (36.7 %)
 Poor 348 (50.2 %)
 Signet ring cell or mucinous 37 (5.3 %)
Bormann type
 I 81 (11.7 %)
 II 161 (23.2 %)
 III 373 (53.8 %)
 IV 78 (11.3 %)
Tumor depth
 T2 92 (13.3 %)
 T3 353 (50.9 %)
 T4 248 (35.8 %)
Lymph node metastasis
 N0 189 (27.3 %)
 N1 154 (22.2 %)
 N2 143 (20.6 %)
 N3 207 (29.9 %)
TNM stage
 I 54 (7.8 %)
 II 259 (37.4 %)
 III 380 (54.8 %)
Lymphatic–vascular invasion
 Yes 439 (63.3 %)
 No 254 (36.7 %)
Neural invasion
 Yes 596 (86.0 %)
 No 97 (14.0 %)
Operation time 218.62 ± 81.36 min
Intraoperative blood loss 243.72 ± 183.95 ml
Clavien–Dindo classification
 I 46 (51.1 %)
Table 1 continued
Characteristics Parameters
 II 16 (17.8 %)
 IIIA 5 (5.6 %)
 IIIB 22 (24.4 %)
 V 1 (1.1 %)
Table 2 Univariate analysis of prognostic factors for Siew-
ert type II patients
Prognostic factors β Hazard ratio  
(95 % CI)
P value
Age 0.354 1.425 (0.990–2.052) 0.057
Gender 0.169 1.184 (0.718–1.954) 0.508
Type of resection 0.366 1.443 (0.979–2.124) 0.064
Length of proximal margin 0.063 1.066 (0.885–1.282) 0.502
Tumor size 0.549 1.732 (1.203–2.494) 0.003
Differentiation status 0.034 1.035 (0.846–1.267) 0.739
Borrmann type 0.352 1.422 (1.104–1.831) 0.006
Tumor depth 0.578 1.782 (1.344–2.362) 0.000
Lymph node metastasis 0.532 1.702 (1.448–2.001) 0.000
TNM stage 0.945 2.573 (1.844–3.591) 0.000
Lymphatic–vascular invasion 1.089 2.970 (1.756–5.026) 0.000
Neural invasion 0.738 2.092 (1.040–4.209) 0.039
Operation time 0.002 1.002 (0.999–1.004) 0.145
Intraoperative blood loss 0.001 1.001 (1.000–1.002) 0.014
Postoperative morbidity (yes/
no)
−0.083 0.921 (0.495–1.712) 0.794
Table 3 Multivariate analysis of prognostic factors for Siew-
ert type II patients
Prognostic factors β Hazard ratio  
(95 % CI)
P value
Age 0.420 1.539 (0.907–2.611) 0.110
Gender −0.103 0.902 (0.475–1.713) 0.753
Type of resection 0.319 1.376 (0.740–2.558) 0.314
Length of proximal margin −0.035 0.965 (0.767–1.215) 0.764
Tumor size −0.008 0.992 (0.594–1.656) 0.975
Differentiation status 0.219 1.245 (0.943–1.644) 0.122
Borrmann type 0.074 1.076 (0.758–1.530) 0.681
Tumor depth 0.111 1.117 (0.710–1.757) 0.632
Lymph node metastasis 0.693 2.000 (1.152–2.525) 0.000
TNM stage 0.169 1.184 (0.475–2.949) 0.717
Lymphatic–vascular invasion 0.523 1.688 (0.911–3.129) 0.096
Neural invasion 0.250 1.285 (0.604–2.731) 0.515
Operation time 0.002 1.002 (0.999–1.005) 0.269
Intraoperative blood loss 0.000 1.000 (0.999–1.001) 0.923
Postoperative morbidity (yes/
no)
0.158 1.171 (0.551–2.488) 0.681
Page 4 of 6Feng et al. SpringerPlus  (2016) 5:588 
of patients with Siewert type II/III AEJ via transhiatal 
approach. We found that the proximal margin length 
does not influence the prognosis of patients with Siewert 
type II/III AEJ.
The optimal surgical approach for Siewert type II 
AEJ has not yet been agreed upon, although both 
transthoracic and transhiatal approach for Siewert type 
II has been attempted in the past few years (Mariette 
et al. 2011). The transthoracic approach is based on the 
principle that the proximal margin length has a critical 
impact on the prognosis, and the transhiatal approach 
is based on evidence that the abdominal lymph node 
metastasis is common and also has a great impact on 
the survival (Yamashita et  al. 2011). The main goal of 
either approach remains complete tumor remove. A 
Dutch group has performed a prospective randomized 
controlled trial to compare the right transthoracic and 
transhiatal approaches for Siewert I/II tumors. As no 
significant difference was noted for prognosis between 
the two approaches, transthoracic approach is not rec-
ommended for Siewert type II tumors (Hulscher et al. 
2002). A Japanese group performed another prospec-
tive randomized controlled trial to compare the effect 
of left thoracoabdominal and transhiatal approaches 
for Siewert II/III tumors with esophageal invasion of 
3 cm or less (Sasako et al. 2006). The result showed that 
left thoracoabdominal approach could not improve the 
survival and will result in increased morbidity after 
operation, although this approach enabled complete 
dissection of the lower mediastinal lymph nodes. A 
meta-analysis conducted by Wei et  al. showed that 
there was no difference in overall survival for Siew-
ert type II AEJ between transthoracic and transhiatal 
approach, but transhiatal approach could decrease 
pulmonary complications and hospital stay (Wei et  al. 
2014). Therefore, the transhiatal approach was recom-
mended for the treatment of Siewert type II/III AEJ 
with esophageal invasion of 3 cm or less (Hosoda et al. 
2015). It was reported that the length of esophageal 
invasion was associated with lower mediastinal lymph 
node metastasis (Nakamura et al. 2012). Thus, for Siew-
ert type II tumors with esophageal invasion more than 
3  cm, mediastinal lymph node dissection via a tran-
sthoracic approach may provide a therapeutic benefit 
(Kurokawa et al. 2015). Given this situation, only Siew-
ert type II/III AEJ patients with esophageal invasion of 
3 cm or less were enrolled in our present study.
Previously, only two studies investigate the impact of 
proximal margin length on the prognosis of AEJ. Bar-
bour et  al. demonstrated that proximal margin greater 
than 3.8  cm is associated with improved prognosis for 
patients with Siewert types I/II/III AEJ that have under-
gone R0 resection with more than 15 lymph nodes exam-
ined (Barbour et al. 2007). However, Mine et al. reported 
that gross proximal margin length of more than 2.0  cm 
seem satisfactory for patients with Siewert type II/III AEJ 
treated by transhiatal approach (Mine et al. 2013). In our 
present study, we found that the proximal margin length 
Table 4 Univariate analysis of prognostic factors for Siew-
ert type III patients
Prognostic factors β Hazard ratio  
(95 % CI)
P value
Age 0.362 1.437 (0.961–2.149) 0.077
Gender 0.090 1.094 (0.598–2.002) 0.771
Type of resection 0.555 1.742 (0.873–3.477) 0.115
Length of proximal margin −0.043 0.958 (0.783–1.171) 0.674
Tumor size 0.759 2.136 (1.397–3.266) 0.000
Differentiation status −0.113 0.893 (0.683–1.167) 0.408
Borrmann type 0.097 1.102 (0.859–1.413) 0.444
Tumor depth 0.242 1.273 (0.921–1.762) 0.144
Lymph node metastasis 0.453 1.572 (1.305–1.894) 0.000
TNM stage 0.733 2.082 (1.407–3.082) 0.000
Lymphatic–vascular invasion 0.611 1.842 (1.066–3.184) 0.029
Neural invasion 1.027 2.792 (1.015–7.697) 0.047
Operation time 0.001 1.001 (1.000–1.003) 0.150
Intraoperative blood loss 0.001 1.001 (1.000–1.002) 0.014
Postoperative morbidity (yes/
no)
0.185 1.203 (0.783–1.846) 0.399
Table 5 Multivariate analysis of  prognostic factors 
for Siewert type III patients
Prognostic factors β Hazard ratio  
(95 % CI)
P value
Age 0.407 1.503 (0.898–2.513) 0.121
Gender 0.270 1.310 (0.651–2.637) 0.450
Type of resection −0.415 0.661 (0.233–1.871) 0.435
Length of proximal margin −0.030 0.970 (0.736–1.279) 0.831
Tumor size 0.555 1.742 (1.025–2.959) 0.040
Differentiation status −0.021 0.979 (0.704–1.360) 0.899
Borrmann type 0.113 1.120 (0.817–1.535) 0.482
Tumor depth 0.190 1.210 (0.689–2.124) 0.508
Lymph node metastasis 0.401 1.493 (1.176–1.895) 0.001
TNM stage −0.174 0.840 (0.303–2.334) 0.739
Lymphatic–vascular invasion 0.100 1.105 (0.600–2.035) 0.748
Neural invasion 0.479 1.615 (0.524–4.978) 0.404
Operation time 0.002 1.002 (0.998–1.006) 0.338
Intraoperative blood loss 0.000 1.000 (0.999–1.001) 0.964
Postoperative morbidity (yes/
no)
0.060 1.061 (0.511–2.206) 0.873
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does not influence the survival of patients with Siewert 
type II/III AEJ with transhiatal approach and R0 resec-
tion. This indicated that negative proximal margin may 
be suficient during the surgical resection of Siewert type 
II/III tumors. The conflict result between our present 
study and previous reports may contribute to several rea-
sons. The most likely reason was that the sample size in 
our present study was significant larger than that in the 
studies reported by Mine et al. (100 cases) and Barbour 
et al. (275 cases with more than 15 lymph nodes exam-
ined). Second, all the three studies were based on single 
center data, which will result in bias. Third, they were all 
retrospective analysis. Thus, multicenter perspective ran-
domized controlled trial should be carried out.
In our present study, the incidence of positive proximal 
margin was approximately 2.0  % (data not shown). The 
incidence was similar to 3.0 % described by Barbour et al. 
(Barbour et  al. 2007) and 1.4  % reported by Mine et  al. 
(2013). It was reported that positive margin was associ-
ated with deeper invasion and tumor size (Shen et al. 2006). 
Patients with stage III and IV disease may have a higher risk 
of sub-clinical intramural tumor infiltration to the esopha-
gus (Bozzetti et al. 2000). Thus, in high risk patients, intra-
operative frozen section analysis is always used to evaluate 
the tumor involvement of the proximal margins.
The influence of positive margin on the survival of 
patients with AEJ remains controversial (Migliore et  al. 
2014). Marriette et  al. have shown that the median sur-
vival time of patients with positive proximal margin was 
significantly lower than that with negative proximal mar-
gin (Mariette et al. 2003). However, DiMusto et al. found 
that 80 % of patients with positive proximal margin died 
with distant metastasis, which would not be influenced 
by more extensive resection (DiMusto and Orringer 
2007). They also found that adjuvant therapy for a posi-
tive margin neither improves prognosis nor reduces local 
recurrence. Shen et al. also reported that positive margin 
was not an independent prognostic factor for survival 
(Shen et al. 2006). Thus, the necessity of extensive resec-
tion during operation when positive margin was demon-
strated by frozen section evaluation and the necessity of 
reoperation when positive margin was found by routine 
pathological examination need further investigation.
There were several limitations in our present study. First, 
it was a retrospective analysis. To clarify the influence of 
proximal margin length on the prognosis of patients, a 
well-designed randomized clinical trial should be carried 
out. Second, the present analysis was limited to proximal 
margins ranging from 0 to 5.0 cm, the influence of proxi-
mal margins more than 5.0 cm were not evaluated. Third, 
the sample size was not large enough. This may result in 
bias during analysis. Fourth, the association between prox-
imal margin length and anastomotic recurrence was not 
investigated. Fifth, the risk factors for positive proximal 
margin were not evaluated in our present study.
Conclusions
For Siewert type II/III AEJ with esophageal invasion 
of 3  cm or less, proximal margin length does not influ-
ence the prognosis of patients after transhiatal curative 
gastrectomy.
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